Latest BIOGEN Científica News & Updates

See the latest news and media coverage for BIOGEN Científica. We track all announcements, press releases, and industry mentions in real time, all in one place.

BIOGEN Científica

Laboratory reagent, instrument, and consumables supplier

biogen.es

Headquarters: Madrid, Spain
Founded year: 1989
Company type: Private company
Number of employees: 15–50
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about BIOGEN Científica

In short: BIOGEN Científica advanced its clinical pipeline with positive lupus data and FDA Fast Track for its Alzheimer’s drug candidate.

Company announcements

September 14 BIOGEN Científica

BIOGEN Científica participates in the SEBBM congress

Share biomedical innovation and connect with sector professionals alongside BLT Imaging partners in Tarragona.

September 1 BIOGEN Científica

BIOGEN Scientific Commercializes the Minitron SE Incubator

The limited version features a fixed configuration optimized for simple processes and will be available until December 18, 2026.

July 15 BIOGEN Científica

BIOGEN Científica sponsors the XV Meeting of GEIRLI

The event focuses on free radicals and oxidative processes, bringing together researchers in El Escorial.

July 9 BIOGEN Científica

Biogen Científica invites to an optogenetics workshop in Barcelona

RWD Life Science organizes a technical session on optogenetics and fiber photometry at the PRBB, Barcelona, on July 13 at 14:00.

Media coverage

March 30 Fierce Biotech

Biogen's litifilimab sparkles in midphase lupus trial, raising hopes for pivotal readout

Biogen's lupus drug candidate litifilimab has improved outcomes in another phase 2 trial, adding to the momentum behind a program barreling toward pivotal data in...

March 26 Yahoo Finance

Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or...

March 19 Yahoo Finance

Biogen Conference: Tau ASO CELIA Updates, Pre-Symptomatic Leqembi, SMA Phase 3 Plans

BIIB080 / CELIA: Biogen's tau ASO BIIB080 (CELIA) is an 18-month proof-of-concept test of intracellular tau lowering — phase 1b showed ~60% CSF tau knockdown...

March 16 Yahoo Finance

Biogen (BIIB) Valuation Check As New SMA Data And Phase 3 Plans Draw Fresh Growth Focus

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Biogen (BIIB) has put fresh attention on its...

Never miss news about BIOGEN Científica

Track BIOGEN Científica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BIOGEN Científica competitors & trending companies

Browse news for competitors to BIOGEN Científica and other trending companies.